Things Left Unsaid
10 minutes was not a lot of time. I’m so disappointed that I
didn’t get to mention the cool EGFP plasmid HHR assay – the test was smart and
straightforward, and then Noreen referred to something similar in lecture an
hour before my presentation, and it would’ve been sooo cool! I also forgot to
mention the initial confirmation assays, and to work in/ran out of time to
critique the paper. I wanted to point out the presence of hydroxyurea in their
in vivo trials, which is a little sketch, but not so much that I’d oppose a
clinical trial. I also didn’t get to rant about the figures. Here follows the
rant: Why did they only average their data ONCE?! Nobody needed to see the
exact data from all 5 of their replicates of each condition. The writers or
editors really should’ve gotten the hint when their figures were LARGER than a
FULL PAGE, and the descriptions of all the different parts that were crammed in
ran over into the footnotes on the next page.
This presentation was so much more work than I thought it
was going to be. Understanding the paper was hard; I think I will vary my
order-reading strategy. But the warm light of comprehension that washed over me
in the last few hours was worth it. All the experiments seem so logical now;
the build neatly off each other. I UNDERSTAND (NOW)!
Comments
Post a Comment